Showing results (261-270 of 511) with videos related to

Sort By:
Pageof 52
Neoplasia (New York, N.Y.)|January 22, 2026
Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic statusAnna Lk Gonye, Linda Orzolek, Christopher Cherry, et al.
Neoplasia (New York, N.Y.)|July 27, 2006
CCL2 is a potent regulator of prostate cancer cell migration and proliferationRobert D Loberg, LaShon L Day, Jason Harwood, et al.
BJU International|July 30, 2016
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillanceMufaddal M Mamawala, Karthik Rao, Patricia Landis, et al.
Cancer Research|April 19, 2007
An imaging biomarker of early treatment response in prostate cancer that has metastasized to the boneKuei C Lee, Sudha Sud, Charles R Meyer, et al.
Nature Reviews. Urology|November 28, 2018
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsiesEmma E van der Toom, Haley D Axelrod, Jean J de la Rosette, et al.
Neoplasia (New York, N.Y.)|February 23, 2012
Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucineOlga V Glinskii, Sudha Sud, Valeri V Mossine, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitmentKosuke Mizutani, Sudha Sud, Natalie A McGregor, et al.
American Journal of Clinical and Experimental Urology|May 11, 2023
Novel urinary tract obstruction marker discovery by multi-marker profiling of urinary extracellular vesicles derived from a rat UTO modelNora M Haney, Chi-Ju Kim, Morgan D Kuczler, et al.
Pageof 52